Guardant Health (GH) Change in Acquisitions & Divestments (2017 - 2026)

Guardant Health (GH) has 10 years of Change in Acquisitions & Divestments data on file, last reported at $954.9 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 210.73% year-over-year to $954.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $647.6 million (up 110.73% YoY) and the FY2024 annual result came in at $35.0 million, up 2186.09% from the prior year.
• Change in Acquisitions & Divestments grew to $954.9 million in Q1 2026 per GH's latest filing, from -$307.3 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $954.9 million in Q1 2026, with the low at -$492.7 million in Q3 2023.
• Average Change in Acquisitions & Divestments over 5 years is $82.6 million, with a median of $49.0 million recorded in 2022.
• The widest YoY moves for Change in Acquisitions & Divestments: up 958.8% in 2023, down 882.06% in 2023.
• Guardant Health's Change in Acquisitions & Divestments stood at -$398.0 million in 2022, then surged by 100.38% to $1.5 million in 2023, then soared by 2186.09% to $35.0 million in 2024, then plunged by 978.07% to -$307.3 million in 2025, then surged by 410.73% to $954.9 million in 2026.
• Business Quant data shows GH's Change in Acquisitions & Divestments at $954.9 million in Q1 2026, -$307.3 million in Q3 2025, and $307.3 million in Q1 2025.